The G1057D polymorphism of insulin receptor substrate-2 associated with gestational diabetes mellitus

Gynecological Endocrinology

Volumn 30, Issue 2, 2014, Pages 165-168

  Ayaz, Lokman ^a   Karakaş Çelik, Sevim ^b   Çayan, Filiz ^c  

^a TRAKYA UNIVERSITY   (Turkey)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^c MERSIN UNIVERSITY   (Turkey)

Author keywords

G1057D polymorphism; GDM; Insulin receptor substrate 2

Indexed keywords

GENOMIC DNA; INSULIN RECEPTOR SUBSTRATE 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; LEUKOCYTE; POLYMERASE CHAIN REACTION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALLELES; DIABETES, GESTATIONAL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY;

EID: 84893095949     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.871516     Document Type: Article

References (30)

1. Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM. Diabetes 1991;40:18-24
2. Buchanan TA, Kjos SL. Gestational diabetes: Risk or myth? J Clin Endocrinol Metab 1999;84:1854-7
3. Catalano PM, Huston L, Amini SB, et al. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903-16
4. Garvey WT, Maianu L, Zhu JH, et al. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes: Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters. Diabetes 1993;42:1773-85
5. Martin AO, Simpson JL, Ober C, Frienkel N. Frequency of diabetes mellitus in mothers of probands with gestational diabetes mellitus: Possible maternal influence on the predisposition to gestational diabetes. Am J Obstet Gynecol 1985;151:471-5
6. Tsai PJ, Ho SC, Tsai LP, et al. Lack of relationship between beta3-adrenergic receptor gene polymorphism and gestational diabetes mellitus in a Taiwanese population. Metabolism 2004;53:1136-9
7. Lauenborg J, Damm P, Ek J, et al. Studies of the Ala/Val98 polymorphism of the hepatocyte nuclear factor-1alpha gene and the relationship to beta-cell function during an OGTT in glucosetolerant women with and without previous gestational diabetes mellitus. Diabet Med 2004;21:1310-15
8. White MF. The insulin signalling system and the IRS proteins. Diabetologia 1997;40:S2-17
9. Almind K, Bjørbaek C, Vestergaard H, et al. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993;342:828-32
10. Hitman GA, Hawrami K, McCarthy MI, et al. Insulin receptor substrate-1 gene mutations in NIDDM, implications for the study of polygenic disease. Diabetologia 1995;38:481-6
11. Clausen JO, Hansen T, Bjørbaek C, et al. Insulin resistance: Interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 1995;346:397-402
12. Sun XJ, Wang L-M, Zhang Y, et al. Role of IRS-2 in insulin and cytokine signalling. Nature 1995;377:173-7
13. Withers DJ, Gutierrez JS, Towery H, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998;391:900-4
14. Withers DJ, Burks DJ, Towery HH, et al. IRS-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 1999;23:32-40
15. Kido Y, Burks DJ, Withers D, et al. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest 2000;105:199-205
16. Kubota N, Tobe K, Terauchi Y, et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 2000;49: 1880-9
17. Stefan N, Kovacs P, Stumvoll M, et al. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. Diabetes 2003;52:1544-50
18. Catalano PM, Nizielski SE, Shao J, et al. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: Relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab 2002; 282:E522-33
19. Tomazic M, Janez A, Sketelj A, et al. Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus. Diabetologia 2002;45:502-8
20. Hoffman L, Nolan C, Wilson JD, et al. Gestational diabetes mellitus-management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust 1998;169:93-7
21. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002;283:E413-22
22. Withers DJ, Gutierrez JS, Towery H, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998;391:900-4
23. Bernal D, Almind K, Yenush L, et al. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes 1998;47:976-9
24. Fritsche A, Madaus A, Renn W, et al. The prevalent Gly1057Asp polymorphism in the insulin receptor substrate-2 gene is not associated with impaired insulin secretion. J Clin Endocrinol Metab 2001;86:4822-5
25. Stefan N, Fritsche A, Machicao F, et al. The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function. Diabetologia 2004;47:759-61
26. D'Alfonso R, Marini MA, Frittita L, et al. Polymorphisms of the IRS-2 in patients with type 2 diabetes. J Clin Endocrinol Metab 2003;88:317-22
27. Okazawa K, Yoshimasa Y, Miyamoto Y, et al. The haplotypes of the IRS-2 gene affect insulin sensitivity in Japanese patients with type 2 diabetes. Diabet Res Clin Prac 2005;68:39-48
28. Mammarella S, Romano F, Di Valerio A, et al. Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. Hum Mol Genet 2000;9:2517-21
29. Catalano PM, Tyzbir ED, Wolfe RR, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 1993;264:E60-7
30. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med 2004;21:103-13.